New

Cabergoline Tablets Market

2021

Cabergoline Tablets Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (0.5mg/Pcs, 1mg/Pcs, and 2mg/Pcs); End Use (Parkinson's Disease (PD), Hyperprolactinemia, and Other), and Geography

| Report Code: TIPRE00023929 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Cabergoline Tablets Market 2028 By Type, End Use, and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Cabergoline belongs to a class of drugs called dopamine agonists. Dopamine is a chemical produced in the human body. It restricts your body from releasing prolactin. Cabergoline binds to dopamine receptors. This also resists your body from releasing prolactin, which assists decrease your prolactin level. Cabergoline is used to treat hyperprolactinemia (high prolactin levels, a natural substance that helps to breastfeed women produce milk but can cause symptoms such as infertility, sexual problems, and bone loss in women who are not breast-feeding or men). Cabergoline oral tablet is a prescription drug that is only available as a generic drug. There is no brand name version available. Cabergoline only comes as a tablet you take by mouth.

MARKET SCOPE

The "Global Cabergoline Tablets Market Analysis to 2028" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Cabergoline tablets market with detailed market segmentation by type, end use, and geography. The report provides key statistics on the market status of the leading Cabergoline tablets market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on type, the global Cabergoline tablets market is segmented into 0.5mg/pcs, 1mg/pcs, 2mg/pcs.
  •  On the basis of end use, the market is segmented into parkinson's disease (pd), hyperprolactinemia, other.

MARKET DYNAMICS
Drivers:

  •   Rise in the incidences of Parkinson's disease.
  •   Rise in the cases of prolactinoma.

Restraints:

  •   The side effects associated with thus medicine is the major restraining factor for this market.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Cabergoline tablets market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Cabergoline tablets market in these regions.

IMPACT OF COVID-19 ON CABERGOLINE TABLETS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Cabergoline tablets market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Cabergoline tablets market are anticipated to lucrative growth opportunities in the future with the rising demand for Cabergoline tablets in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Cabergoline tablets market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Pfizer
  •  Teva
  •  Sun Pharmaceutical
  •  Mylan
  •  Neon Laboratories Ltd.
  •  Serum Institute of India Pvt. Ltd.
  •  TTK Healthcare Ltd.
  •  Cipla
  •  Intas Pharmaceuticals
  •  Vivo Life Sciences
The Insight Partner's dediCabergoline tabletsed research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cabergoline Tablets Market - By Type
1.3.2 Cabergoline Tablets Market - By End Use
1.3.3 Cabergoline Tablets Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CABERGOLINE TABLETS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CABERGOLINE TABLETS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CABERGOLINE TABLETS MARKET - GLOBAL MARKET ANALYSIS
6.1. CABERGOLINE TABLETS - GLOBAL MARKET OVERVIEW
6.2. CABERGOLINE TABLETS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. CABERGOLINE TABLETS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. 0.5MG/PCS
7.3.1. Overview
7.3.2. 0.5mg/Pcs Market Forecast and Analysis
7.4. 1MG/PCS
7.4.1. Overview
7.4.2. 1mg/Pcs Market Forecast and Analysis
7.5. 2MG/PCS
7.5.1. Overview
7.5.2. 2mg/Pcs Market Forecast and Analysis
8. CABERGOLINE TABLETS MARKET - REVENUE AND FORECASTS TO 2028 - END USE
8.1. OVERVIEW
8.2. END USE MARKET FORECASTS AND ANALYSIS
8.3. PARKINSON'S DISEASE (PD)
8.3.1. Overview
8.3.2. Parkinson's Disease (PD) Market Forecast and Analysis
8.4. HYPERPROLACTINEMIA
8.4.1. Overview
8.4.2. Hyperprolactinemia Market Forecast and Analysis
8.5. OTHER
8.5.1. Overview
8.5.2. Other Market Forecast and Analysis
9. CABERGOLINE TABLETS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Cabergoline Tablets Market Overview
9.1.2 North America Cabergoline Tablets Market Forecasts and Analysis
9.1.3 North America Cabergoline Tablets Market Forecasts and Analysis - By Type
9.1.4 North America Cabergoline Tablets Market Forecasts and Analysis - By End Use
9.1.5 North America Cabergoline Tablets Market Forecasts and Analysis - By Countries
9.1.5.1 United States Cabergoline Tablets Market
9.1.5.1.1 United States Cabergoline Tablets Market by Type
9.1.5.1.2 United States Cabergoline Tablets Market by End Use
9.1.5.2 Canada Cabergoline Tablets Market
9.1.5.2.1 Canada Cabergoline Tablets Market by Type
9.1.5.2.2 Canada Cabergoline Tablets Market by End Use
9.1.5.3 Mexico Cabergoline Tablets Market
9.1.5.3.1 Mexico Cabergoline Tablets Market by Type
9.1.5.3.2 Mexico Cabergoline Tablets Market by End Use
9.2. EUROPE
9.2.1 Europe Cabergoline Tablets Market Overview
9.2.2 Europe Cabergoline Tablets Market Forecasts and Analysis
9.2.3 Europe Cabergoline Tablets Market Forecasts and Analysis - By Type
9.2.4 Europe Cabergoline Tablets Market Forecasts and Analysis - By End Use
9.2.5 Europe Cabergoline Tablets Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Cabergoline Tablets Market
9.2.5.1.1 Germany Cabergoline Tablets Market by Type
9.2.5.1.2 Germany Cabergoline Tablets Market by End Use
9.2.5.2 France Cabergoline Tablets Market
9.2.5.2.1 France Cabergoline Tablets Market by Type
9.2.5.2.2 France Cabergoline Tablets Market by End Use
9.2.5.3 Italy Cabergoline Tablets Market
9.2.5.3.1 Italy Cabergoline Tablets Market by Type
9.2.5.3.2 Italy Cabergoline Tablets Market by End Use
9.2.5.4 Spain Cabergoline Tablets Market
9.2.5.4.1 Spain Cabergoline Tablets Market by Type
9.2.5.4.2 Spain Cabergoline Tablets Market by End Use
9.2.5.5 United Kingdom Cabergoline Tablets Market
9.2.5.5.1 United Kingdom Cabergoline Tablets Market by Type
9.2.5.5.2 United Kingdom Cabergoline Tablets Market by End Use
9.2.5.6 Rest of Europe Cabergoline Tablets Market
9.2.5.6.1 Rest of Europe Cabergoline Tablets Market by Type
9.2.5.6.2 Rest of Europe Cabergoline Tablets Market by End Use
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Cabergoline Tablets Market Overview
9.3.2 Asia-Pacific Cabergoline Tablets Market Forecasts and Analysis
9.3.3 Asia-Pacific Cabergoline Tablets Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Cabergoline Tablets Market Forecasts and Analysis - By End Use
9.3.5 Asia-Pacific Cabergoline Tablets Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Cabergoline Tablets Market
9.3.5.1.1 Australia Cabergoline Tablets Market by Type
9.3.5.1.2 Australia Cabergoline Tablets Market by End Use
9.3.5.2 China Cabergoline Tablets Market
9.3.5.2.1 China Cabergoline Tablets Market by Type
9.3.5.2.2 China Cabergoline Tablets Market by End Use
9.3.5.3 India Cabergoline Tablets Market
9.3.5.3.1 India Cabergoline Tablets Market by Type
9.3.5.3.2 India Cabergoline Tablets Market by End Use
9.3.5.4 Japan Cabergoline Tablets Market
9.3.5.4.1 Japan Cabergoline Tablets Market by Type
9.3.5.4.2 Japan Cabergoline Tablets Market by End Use
9.3.5.5 South Korea Cabergoline Tablets Market
9.3.5.5.1 South Korea Cabergoline Tablets Market by Type
9.3.5.5.2 South Korea Cabergoline Tablets Market by End Use
9.3.5.6 Rest of Asia-Pacific Cabergoline Tablets Market
9.3.5.6.1 Rest of Asia-Pacific Cabergoline Tablets Market by Type
9.3.5.6.2 Rest of Asia-Pacific Cabergoline Tablets Market by End Use
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Cabergoline Tablets Market Overview
9.4.2 Middle East and Africa Cabergoline Tablets Market Forecasts and Analysis
9.4.3 Middle East and Africa Cabergoline Tablets Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Cabergoline Tablets Market Forecasts and Analysis - By End Use
9.4.5 Middle East and Africa Cabergoline Tablets Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Cabergoline Tablets Market
9.4.5.1.1 South Africa Cabergoline Tablets Market by Type
9.4.5.1.2 South Africa Cabergoline Tablets Market by End Use
9.4.5.2 Saudi Arabia Cabergoline Tablets Market
9.4.5.2.1 Saudi Arabia Cabergoline Tablets Market by Type
9.4.5.2.2 Saudi Arabia Cabergoline Tablets Market by End Use
9.4.5.3 U.A.E Cabergoline Tablets Market
9.4.5.3.1 U.A.E Cabergoline Tablets Market by Type
9.4.5.3.2 U.A.E Cabergoline Tablets Market by End Use
9.4.5.4 Rest of Middle East and Africa Cabergoline Tablets Market
9.4.5.4.1 Rest of Middle East and Africa Cabergoline Tablets Market by Type
9.4.5.4.2 Rest of Middle East and Africa Cabergoline Tablets Market by End Use
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Cabergoline Tablets Market Overview
9.5.2 South and Central America Cabergoline Tablets Market Forecasts and Analysis
9.5.3 South and Central America Cabergoline Tablets Market Forecasts and Analysis - By Type
9.5.4 South and Central America Cabergoline Tablets Market Forecasts and Analysis - By End Use
9.5.5 South and Central America Cabergoline Tablets Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Cabergoline Tablets Market
9.5.5.1.1 Brazil Cabergoline Tablets Market by Type
9.5.5.1.2 Brazil Cabergoline Tablets Market by End Use
9.5.5.2 Argentina Cabergoline Tablets Market
9.5.5.2.1 Argentina Cabergoline Tablets Market by Type
9.5.5.2.2 Argentina Cabergoline Tablets Market by End Use
9.5.5.3 Rest of South and Central America Cabergoline Tablets Market
9.5.5.3.1 Rest of South and Central America Cabergoline Tablets Market by Type
9.5.5.3.2 Rest of South and Central America Cabergoline Tablets Market by End Use
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CABERGOLINE TABLETS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CABERGOLINE TABLETS MARKET, KEY COMPANY PROFILES
12.1. PFIZER
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. TEVA
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SUN PHARMACEUTICAL
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MYLAN
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. NEON LABORATORIES LTD.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SERUM INSTITUTE OF INDIA PVT. LTD.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. TTK HEALTHCARE LTD.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. CIPLA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. INTAS PHARMACEUTICALS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. VIVO LIFE SCIENCES
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer
2. Teva
3. Sun Pharmaceutical
4. Mylan
5. Neon Laboratories Ltd.
6. Serum Institute of India Pvt. Ltd.
7. TTK Healthcare Ltd.
8. Cipla
9. Intas Pharmaceuticals
10. Vivo Life Sciences
11. Zydus Healthcare
12. Cubit Healthcare
13. Eris Lifesciences
14. Amigoz Lifesciences
15. Innovative Pharmaceuticals
TIPRE00023929
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.